second quarter 2026
Filed Aug 4, 2026GXO Reports Second Quarter 2026 Results
Revenue, organic revenue, adjusted EBITDA and adjusted diluted EPS increased year over year, while cash flow from operations and free cash flow improved materially. GAAP net income and diluted EPS were modestly lower year over year, and the company maintained the mid-points of its full-year adjusted EBITDA and adjusted diluted EPS guidance ranges.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| RevenueGAAP | $3.4 billion | – | up 4.3% year over year |
| Organic revenuenon-GAAP | . | – | grew by 3.4% |
| Net incomeGAAP | $27 million | – | – |
| Diluted earnings per shareGAAP | $0.22 | – | – |
| Adjusted EBITDAnon-GAAP | $219 million | – | increased |
| Adjusted diluted EPSnon-GAAP | $0.59 | – | increased |
| Cash flow from operationsGAAP | $76 million | – | – |
| Free cash flownon-GAAP | $12 million | – | – |
| New business winsother | $410 million | – | up 34% year over year |
| Incremental 2026 revenueother | Approximately $1 billion | – | up 29% year over year |
| Incremental 2027 revenue already securedother | $353 million | – | – |
| Commercial pipeline at the end of the quarterother | $2.3 billion | – | – |
| Commercial pipeline in Julyother | approximately $2.7 billion | – | – |
full year 2026 outlook
- NoteOrganic revenue growth of 4% to 5%
- NoteAdjusted EBITDA of $945 million to $965 million (previously $935 million to $975 million)
- NoteAdjusted diluted EPS of $2.95 to $3.15 (previously $2.90 to $3.20)
- NoteFree cash flow conversion of 30% to 40%
What drove it
- All three regions grew organically.
- New business wins were led by aerospace & defense, technology, industrial and life sciences.
- Approximately 40% of new business wins were in strategic growth verticals.
- North America wins in the first half of the year increased 85% over the same time last year.
- GXO launched the GXO Way playbook.
- GXO IQ moved from platform launch to scaled deployment.
Concerns
- Net income was $27 million, compared with $28 million for the second quarter 2025.
- Diluted earnings per share was $0.22, compared with $0.23 for the second quarter 2025.
- The filing does not report gross margin, operating income, segment-level revenue, or margin metrics in the provided text.
- Total debt outstanding was $3.2 billion and net debt was $2.4 billion as of June 30, 2026.
What to watch
- Delivery against full-year 2026 organic revenue growth guidance of 4% to 5%.
- Conversion of approximately $1 billion of incremental 2026 revenue already secured into reported revenue.
- Progress in the commercial pipeline, which expanded from $2.3 billion at the end of the quarter to approximately $2.7 billion in July.
- Free cash flow conversion against full-year 2026 guidance of 30% to 40%.
- Management's long-term strategy, financial framework and value creation opportunities at the 2026 Investor Day on November 16, 2026.
Balance sheet and cash flow
- Cash and cash equivalents (excluding restricted cash) were $769 million as of June 30, 2026.
- Total debt outstanding was $3.2 billion as of June 30, 2026.
- Net debt was $2.4 billion as of June 30, 2026.
- GXO generated $76 million of cash flow from operations, compared with $3 million for the second quarter 2025.
- GXO generated $12 million of free cash flow, compared with $43 million used for the second quarter 2025.
Analysis
GXO reported second-quarter 2026 revenue of $3.4 billion, up 4.3% year over year, with organic revenue growth of 3.4%. Management said all three regions grew organically. Commercial activity was a central positive: new business wins were $410 million, up 34% year over year, and approximately 40% of those wins were in aerospace & defense, technology, industrial and life sciences.
Profitability was mixed across reported measures. Adjusted EBITDA increased to $219 million from $212 million, while adjusted diluted EPS increased to $0.59 from $0.57. In contrast, GAAP net income was $27 million versus $28 million, and GAAP diluted EPS was $0.22 versus $0.23. The provided text does not include gross margin, operating income, adjusted EBITDA margin, or segment profitability, limiting assessment of the underlying margin progression.
Cash generation improved from the prior-year quarter. Cash flow from operations was $76 million compared with $3 million, and free cash flow was $12 million compared with $43 million used. At June 30, 2026, cash and cash equivalents excluding restricted cash were $769 million, total debt outstanding was $3.2 billion, and net debt was $2.4 billion. The provided text does not report repurchases, dividends, capital expenditures, or debt maturities.
The company guided to full-year 2026 organic revenue growth of 4% to 5%, adjusted EBITDA of $945 million to $965 million, adjusted diluted EPS of $2.95 to $3.15, and free cash flow conversion of 30% to 40%. The adjusted EBITDA and adjusted diluted EPS ranges were narrowed from the previously stated ranges while retaining their mid-points. GXO also cited approximately $1 billion of incremental 2026 revenue already secured, $353 million of incremental 2027 revenue already secured, and commercial pipeline expansion to approximately $2.7 billion in July as indicators of forward commercial momentum.
Management, verbatim
This quarter marks five years since GXO became an independent public company, and we delivered results that reflect the momentum building across our business, including our strongest new business wins in three years.
Patrick Kelleher, chief executive officer of GXO
With over $1 billion of incremental revenue already secured for 2026 and a commercial pipeline that has expanded from $2.3 billion at the end of the quarter to approximately $2.7 billion in July, we have strong visibility into the balance of the year and are already building momentum into 2027.
Patrick Kelleher, chief executive officer of GXO
Not in the filing
stated, not guessed- GAAP operating income
- Gross profit and gross margin
- Operating expenses
- Segment names and segment-level revenue
- Segment-level year-over-year and sequential comparisons
- Prior-quarter comparisons for reported metrics
- Adjusted EBITDA margin
- Adjusted EBITA and adjusted EBITA margin
- Adjusted net income attributable to GXO
- Basic earnings per share
- Tax rate
- Capital expenditures
- Share repurchases
- Dividends
- Debt maturities
- Net leverage ratio
- Operating return on invested capital
- Weighted-average shares outstanding
- Prior outlook section for formal actual-versus-prior-guidance comparisons
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.